You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent pancreatic cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Carcinoma Trial in Shanghai (carbon ion radiotherapy)

Recruiting
  • Pancreatic Carcinoma
  • carbon ion radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Apr 25, 2023

Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • C3 (Metformin, Simvastatin, and Digoxin)
  • (no location specified)
Sep 1, 2023

Pancreatic Cancer Trial in Baltimore, Dallas (ARQ-761, Gemcitabine, nab-paclitaxel)

Terminated
  • Pancreatic Cancer
  • Baltimore, Maryland
  • +1 more
May 31, 2022

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Pancreatic Cancer Trial in Shanghai (Cyberknife plus Pembrolizumab and Trametinib, Cyberknife plus Gemcitabine)

Completed
Has Results
  • Pancreatic Cancer
  • Cyberknife plus Pembrolizumab and Trametinib
  • Cyberknife plus Gemcitabine
  • Shanghai, Shanghai, China
    Changhai hospital
Feb 28, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • +4 more
  • Aurora, Colorado
  • +1 more
Sep 8, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Solid Tumor, Recurrent Colorectal Carcinoma Trial in Winston-Salem

Completed
  • Metastatic Malignant Neoplasm in the Brain
  • +11 more
  • Laboratory Biomarker Analysis
  • siRNA-transfected Peripheral Blood Mononuclear Cells APN401
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Recurrent Pancreatic Cancer Trial in Shanghai (Tislelizumab, Nab paclitaxel, Gemcitabine)

Recruiting
  • Recurrent Pancreatic Cancer
  • Shanghai, China
    Changhai Hospital
May 25, 2021

PDAC, Pancreatoduodenectomy, Margin, Resection Trial in Duesseldorf (oncological relevance of the mesopancreas)

Not yet recruiting
  • PDAC
  • +4 more
  • oncological relevance of the mesopancreas
  • Duesseldorf, Germany
    University Hospital Duesseldorf, Heinrich Heine University
May 30, 2023

Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

Active, not recruiting
  • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
  • +27 more
  • Los Angeles, California
  • +2 more
Aug 5, 2022

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Active, not recruiting
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • 6,8-bis(benzylthio)octanoic acid
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 22, 2021

Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,

Active, not recruiting
  • Colorectal Adenocarcinoma
  • +14 more
  • Atlanta, Georgia
  • +2 more
Jul 5, 2022

Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib

Completed
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Afatinib Dimaleate
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Jun 3, 2022

Pancreatic Cancer Trial in Stockholm (Mistletoe extract (Iscador Qu), Placebo)

Active, not recruiting
  • Pancreatic Cancer
  • Mistletoe extract (Iscador Qu)
  • Placebo
  • Stockholm, Sweden
    Kathrin Wode
Mar 14, 2022

Resectable Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Ductal Adenocarcinoma Trial in Netherlands (Standardized

Enrolling by invitation
  • Resectable Pancreatic Ductal Adenocarcinoma
  • Recurrent Pancreatic Ductal Adenocarcinoma
  • Standardized surveillance
  • Nijmegen, Gelderland, Netherlands
  • +8 more
May 17, 2022

Recurrent Pancreatic Ductal Adenocarcinoma Trial in Amsterdam, Rotterdam, Utrecht (Additional stereotactic body radiation

Enrolling by invitation
  • Recurrent Pancreatic Ductal Adenocarcinoma
  • Additional stereotactic body radiation therapy
  • Amsterdam, Noord-Holland, Netherlands
  • +2 more
May 17, 2022

Pancreatic Cancer, Periampullary Adenocarcinoma Trial in Baltimore (Stereotactic Body Radiation Therapy (SBRT))

Active, not recruiting
  • Pancreatic Cancer
  • Periampullary Adenocarcinoma
  • Stereotactic Body Radiation Therapy (SBRT)
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 9, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in Bronx

Completed
Has Results
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
May 18, 2021

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
Has Results
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • metformin hydrochloride
  • +4 more
  • Cleveland, Ohio
  • +1 more
Aug 9, 2021

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Pancreatic Cancer Trial in Nanjing, Jinan (Z650, Gemcitabine)

Recruiting
  • Pancreatic Cancer
  • Nanjing, China/jiangsu, China
  • +1 more
Mar 22, 2021

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • CXCR4 Antagonist BL-8040
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Benign Pancreatic Tumor, Chronic Pancreatitis, Recurrent Acute Pancreatitis Trial in Portland (Pancreatectomy, Quality-of-Life

Not yet recruiting
  • Benign Pancreatic Neoplasm
  • +2 more
  • Pancreatectomy
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 7, 2022

Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Stanford, California
    Stanford University Medical Center
Apr 8, 2021